Progyny is a $2.1 billion dollar company that is a leader in the fertility treatment industry. As we analyze the company, we'll find that this stock is an intriguing stock that seems to be under Wall Street's radar. This company doesn't have a PE ratio but because it has been improving its financials and doesn't display signs of diseconomies of scale, it's safe to say that one day, it can become profitable.
*This is not financial advice. All content should be considered opinionated. We are not responsible for any of your gains and losses. I am neither a licensed or registered financial expert. Please see a financial advisor before making investment decisions.
Blogpost: Dissecting the Markets
---
Send in a voice message: https://anchor.fm/hardwoodtile/message
Support this podcast: https://anchor.fm/hardwoodtile/support